Quarterly report pursuant to Section 13 or 15(d)

Stock Compensation Plan (Tables)

v3.24.2.u1
Stock Compensation Plan (Tables)
 6 Months Ended
Jun. 30, 2024
Share-Based Payment Arrangement [Abstract]  
Summary of Stock Option Activity

A summary of stock option activity for the six months ended June 30, 2024 is as follows:

 

   

Number of

Shares

    

Weighted

Average

Exercise Price

    

Weighted Average

Remaining Contractual

Term (In Years)

    

Aggregate

Intrinsic Value(1)

  
Outstanding at December 31, 2023     244,733     $ 20.17       7.96     $ —  
Granted     —       —       —     $ —  
Expired     (17,146 )     28.44       —     $ —  
Forfeited     (4,667 )     11.52             $ —  
Outstanding at June 30, 2024     222,920     $ 19.72       8.29     $ —  
                                 
Exercisable at June 30, 2024     186,370     $ 22.55       8.07     $ —  

 

(1) The aggregate intrinsic value is calculated as the difference between the exercise price of the underlying stock option awards and the closing market price of our common stock as of December 31, 2023 and June 30, 2024; respectively.
Schedule of Restricted Stock Activity

Restricted stock grant activity during the six months ended June 30, 2024 was as follows:

 

 Schedule of Restricted Stock Activity

    Number of Shares    

Weighted

Average

Grant Date

Fair Value

  
Non-vested restricted stock at December 31, 2023     6,000     $ 3.37  
Vested     (6,000 )     3.37  
Non-vested restricted stock at June 30, 2024     —     $ —  

 

Total compensation cost related to restricted stock awards was approximately $5,000 for the six months ended June 30, 2024. There was no compensation cost related to restricted stock awards for the three months ended June 30, 2024.